Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

46.97
Delayed Data
As of Jan 20
 +0.27 / +0.58%
Today’s Change
19.59
Today|||52-Week Range
57.00
-1.80%
Year-to-Date
Biogen's Multiple Sclerosis Franchise to Drive Growth in 2017
Jan 17 / Zacks.com - Paid Partner Content
The 1 Biotech Stock I Want to Own in 2017
Jan 11 / MotleyFool.com - Paid Partner Content
Is Biogen's Stock Ready to Heat Up After a Forgettable 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content
Why Ionis Pharmaceuticals Shares Fell by 22.8% in 2016
Jan 12 / MotleyFool.com - Paid Partner Content
Ionis, Novartis Ink Deal to Focus on Cardiovascular Treatments
Jan 09 / Zacks.com - Paid Partner Content
Company News for January 11, 2017
Jan 11 / Zacks.com - Paid Partner Content